Marc Martinez-Llordella, PhD

VP Biology & Founder
Quell Therapeutics, United Kingdom

Poster(s):

• Th143 - Engineering of Regulatory T Cells with Hepatocyte-specific Chimeric Antigen Receptor Enhances Liver Tissue Trafficking
  Thursday, June 26, 2025

  7:30am - 7:45pm East Coast USA Time

• Tu154 - Use of Engineered CAR-Treg Cells to Induce Immune Tolerance in Liver Transplantation – Insights from the LIBERATE Clinical Trial
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time

• Tu158 - Affinity-tuning of Human anti-HLA-A2 Chimeric Antigen Receptors Enhances Their Function
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time